Harvard's Dana-Farber Cancer Institute Retracts Six Studies, Corrects 31 Others Amid Data Falsification Allegations

Top researchers, including the institute's CEO, are under scrutiny following claims of data forgery by British molecular biologist Dr. Sholto David.

Harvard-affiliated Dana-Farber Cancer Institute is retracting six studies and correcting 31 others following allegations of data falsification.
British molecular biologist Dr. Sholto David accused the institute of data forgery in a blog post, leading to an internal investigation.
Four top researchers at the institute, all faculty members at Harvard Medical School, are under scrutiny, including the institute's CEO, Dr. Laurie Glimcher.
Over 50 papers are due for review, and the investigation may continue for up to a year.
The allegations follow recent plagiarism accusations against former Harvard President Claudine Gay, who resigned earlier this month.